Literature DB >> 3938408

Phosphocreatine content and intracellular pH of calf muscle measured by phosphorus NMR spectroscopy in occlusive arterial disease of the legs.

U Keller, R Oberhänsli, P Huber, L K Widmer, W P Aue, R I Hassink, S Müller, J Seelig.   

Abstract

Energy metabolism of calf muscle was assessed non-invasively by phosphorus (31P) NMR spectroscopy in eleven patients with symptomatic arterial occlusion and in seven matched controls. Phosphocreatine (PCr) content and pH values decreased during non-ischaemic foot exercise to lower values in severely afflicted patients but in all patients, as a group, they were not significantly decreased compared to controls. In contrast, recovery from ischaemic exercise (arterial occlusion by a tourniquet) demonstrated significant differences between patients and controls. Intracellular pH and PCr recovered more slowly in patients than in controls; PCr recovery proceeded exponentially with a recovery half-time of 203 +/- 74 s in patients compared to 36.7 +/- 5.5 s in controls (P less than 0.02). Phosphocreatine (PCr) recovery after ischaemic exercise correlated significantly with the degree of arterial stenoses as assessed by Doppler ultrasound (r = 0.739, P = 0.019) and by angiography (r = 0.885, P = 0.005), suggesting that the degree of large vessel stenoses limits the postischaemic increase in mitochondrial oxidative phosphorylation. Reactive blood flow after ischaemia failed to correlate with PCr recovery or with the degree of arterial stenoses. Phosphorus (31P) NMR spectroscopy provides, therefore, quantitative parameters of muscle energy metabolism in patients with peripheral arterial occlusions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3938408     DOI: 10.1111/j.1365-2362.1985.tb00289.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  17 in total

1.  Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease.

Authors:  David C Isbell; Stuart S Berr; Alicia Y Toledano; Frederick H Epstein; Craig H Meyer; Walter J Rogers; Nancy L Harthun; Klaus D Hagspiel; Arthur Weltman; Christopher M Kramer
Journal:  J Am Coll Cardiol       Date:  2006-05-15       Impact factor: 24.094

Review 2.  Nuclear magnetic resonance in clinical pharmacology and measurement of therapeutic response.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

3.  A gated 31P-n.m.r. study of bioenergetic recovery in rat skeletal muscle after tetanic contraction.

Authors:  R A Challiss; M J Blackledge; E A Shoubridge; G K Radda
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

Review 4.  Disruption of mitochondrial quality control in peripheral artery disease: New therapeutic opportunities.

Authors:  Cintia B Ueta; Katia S Gomes; Márcio A Ribeiro; Daria Mochly-Rosen; Julio C B Ferreira
Journal:  Pharmacol Res       Date:  2016-11-19       Impact factor: 7.658

5.  Rapid 3D-imaging of phosphocreatine recovery kinetics in the human lower leg muscles with compressed sensing.

Authors:  Prodromos Parasoglou; Li Feng; Ding Xia; Ricardo Otazo; Ravinder R Regatte
Journal:  Magn Reson Med       Date:  2012-09-28       Impact factor: 4.668

6.  Dynamic phosphocreatine imaging with unlocalized pH assessment of the human lower leg muscle following exercise at 3T.

Authors:  Oleksandr Khegai; Guillaume Madelin; Ryan Brown; Prodromos Parasoglou
Journal:  Magn Reson Med       Date:  2017-05-30       Impact factor: 4.668

7.  Dynamic three-dimensional imaging of phosphocreatine recovery kinetics in the human lower leg muscles at 3T and 7T: a preliminary study.

Authors:  Prodromos Parasoglou; Ding Xia; Gregory Chang; Ravinder R Regatte
Journal:  NMR Biomed       Date:  2012-10-13       Impact factor: 4.044

8.  Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD-SelMQC-CSI) on a clinical MRI scanner: Application to tumors and muscle ischemia.

Authors:  Eric A Mellon; Seung-Cheol Lee; Stephen Pickup; Sungheon Kim; Steven C Goldstein; Thomas F Floyd; Harish Poptani; E James Delikatny; Ravinder Reddy; Jerry D Glickson
Journal:  Magn Reson Med       Date:  2009-12       Impact factor: 4.668

9.  Peripheral arterial disease assessment: wall, perfusion, and spectroscopy.

Authors:  Christopher M Kramer
Journal:  Top Magn Reson Imaging       Date:  2007-10

10.  Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma.

Authors:  N S Cook; I D Chapman
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.